UMMS Affiliation

Department of Molecular Genetics and Microbiology

Publication Date


Document Type



Animals; *Bacterial Adhesion; Binding, Competitive; *Borrelia burgdorferi; Borrelia burgdorferi Group; Cercopithecus aethiops; Glycosaminoglycans; Hemagglutination Tests; Heparin; Structure-Activity Relationship; Vero Cells


Microbiology | Molecular Genetics


Borrelia burgdorferi, the Lyme disease agent, binds glycosaminoglycans (GAGs) such as heparin, heparan sulfate, and dermatan sulfate. Heparin or heparan sulfate fractions separated by size or charge were tested for their ability to inhibit attachment of B. burgdorferi to Vero cells. GAG chains of increasing length and/or charge showed increasing inhibitory potency, and detectable heparin inhibition of bacterial binding required a minimum of 16 residues. The ability of a given heparin fraction to inhibit binding to Vero cells was strongly predictive of its ability to inhibit hemagglutination, suggesting that hemagglutination reflects the capacity of B. burgdorferi to bind to GAGs.


Infect Immun. 1998 Dec;66(12):6045-8.

Journal/Book/Conference Title

Infection and immunity

Related Resources

Link to Article in PubMed

PubMed ID




To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.